Business, energy, technology, markets and global industry news from Business News Today

ACC 2026

PharmaDeviceNews ACC 2026
Representative image of blood pressure research and cardiovascular drug development, illustrating Kardigan’s tonlamarsen Phase 2 hypertension study and the growing focus on acute severe hypertension treatment.
Pharma & Biotech

Why Kardigan’s Phase 2 tonlamarsen results matter more for acute severe hypertension than chronic blood pressure care

Kardigan’s tonlamarsen showed Phase 2 promise in hypertension, but can it win in acute severe hypertension next? Read the deeper analysis.

Read More
Medical Devices & Diagnostics

CorVista Health expands machine-learning diagnostics to INOCA with new ACC.26 poster data

CorVista Health presents machine-learned non-invasive INOCA detection data at ACC.26. Analysis of what this means for cardiology and women's heart care. Read more.

Read More
Viz.ai’s HCM data push shows why cardiac AI is shifting from detection to care coordination
Medical Devices & Diagnostics

What Viz.ai’s latest hypertrophic cardiomyopathy studies reveal about the future of cardiac AI

Viz.ai’s new HCM studies suggest AI-ECG could improve detection and follow-up. Read what this changes for cardiology workflows and adoption.

Read More